5881 - 5890 of 7916 Results
Title
Year
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Beyond L-DOPA: hope for Parkinson’s treatment and diagnosisJournal Name: EBioMedicinePublisher: Elsevier BVVol: 23Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2017.09.009Best OA location URL: http://www.ebiomedicine.com/article/S2352396417303626/pdfCitation Count: 0
-
RESTRICTEDTitle: Detection, risk factors, and functional consequences of cerebral microinfarctsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 730End Page: 740Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/s1474-4422(17)30196-5Best OA location URL: http://manuscript.elsevier.com/S1474442217301965/pdf/S1474442217301965.pdfCitation Count: 230
-
OPENTitle: Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 9Start Page: e0184117End Page: e0184117Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0184117Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184117&type=printableCitation Count: 13
-
RESTRICTEDTitle: Effects of α-synuclein on axonal transportJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 321End Page: 327Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2016.12.008Best OA location URL: http://manuscript.elsevier.com/S0969996116302893/pdf/S0969996116302893.pdfCitation Count: 52
-
RESTRICTEDTitle: Erythropoietin and small molecule agonists of the tissue-protective erythropoietin receptor increase FXN expression in neuronal cells in vitro and in Fxn-deficient KIKO mice in vivoJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 123Issue #:Start Page: 34End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2017.05.011Citation Count: 10
-
OPENTitle: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic NeurodegenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 84End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014Best OA location URL: https://europepmc.org/articles/pmc5701756?pdf=renderCitation Count: 142
-
OPENTitle: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6354Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaf3934Best OA location URL: https://science.sciencemag.org/content/sci/357/6354/891.full.pdfCitation Count: 367
-
RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 143
-
OPENTitle: Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1439End Page: 1446Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27125Best OA location URL: https://europepmc.org/articles/pmc5931206?pdf=renderCitation Count: 23